中低收入国家孕产妇围产期抗生素预防的范围综述:与WHO建议的比较
该范围综述检索了Medline、Embase、Global Health、LILACS和WHO图书馆数据库,纳入2015年以来中低收入国家发表的关于B族链球菌(GBS)、未足月胎膜早破(PPROM)、剖宫产、手法胎盘剥离及三度/四度会阴裂伤的孕产妇预防性抗生素文献。共纳入来自13个国家的27项研究、涉及43774名妇女。GBS的聚合酶链反应筛查可行但受资金限制;PPROM中高达42%的GBS分离株对红霉素耐药;剖宫产抗生素预防证据大体支持WHO建议,但存在延长疗程或多药方案的报告。结论认为现有证据不足以挑战WHO预防围产期感染的建议,但实施存在挑战,鉴于抗菌药物耐药的出现,需要研究以确保围产期预防性抗生素选择仍然有效。
要点
- 共纳入来自13个中低收入国家的27项研究、43774名妇女,比较围产期预防性抗生素使用与WHO建议。
- PPROM中高达42%的GBS分离株对红霉素耐药,提示红霉素耐药需关注。
- GBS的聚合酶链反应筛查在中低收入国家可行,但受资金限制。
- 剖宫产抗生素预防证据大体支持WHO建议,但报告了延长疗程或多药方案的使用。
- 现有证据不足以挑战当前WHO预防围产期感染的建议,但实施挑战存在。
适用人群与场景
- 中低收入国家中接受围产期预防性抗生素的孕产妇,涉及GBS、PPROM、剖宫产、手法胎盘剥离及三度/四度会阴裂伤等情形。
研究设计与关键结果
- 范围综述检索Medline、Embase、Global Health、LILACS和WHO图书馆数据库,纳入2015年以来中低收入国家发表的关于GBS、PPROM、剖宫产、手法胎盘剥离及三度/四度会阴裂伤的孕产妇预防性抗生素文献。
- 共纳入来自13个国家的27项研究、涉及43774名妇女。
- GBS的聚合酶链反应筛查可行,但受资金限制。
- PPROM中高达42%的GBS分离株对红霉素耐药。
- 剖宫产抗生素预防证据大体支持WHO建议,但报告了延长疗程或多药方案。
证据类型、等级与局限
- 证据类型:范围综述,遵循PRISMA指南,因研究异质性采用叙述性综合。
- 局限:原文未报告局限性。
对床旁实践的改变
- 现有证据不足以挑战当前WHO预防围产期感染的建议。
- 实施挑战存在,鉴于抗菌药物耐药的出现,需要研究以确保围产期预防性抗生素选择仍然有效。
指南或共识出处
- WHO关于预防和治疗孕产妇围产期感染的建议。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a leading cause of maternal death. Antimicrobials save lives, but inappropriate overuse increases risk of antimicrobial resistance.
OBJECTIVE: A scoping review comparing peripartum prophylactic antimicrobial use in low- and middle-income countries (LMICs) with WHO recommendations for prevention and treatment of maternal peripartum infection.
SEARCH STRATEGY: Medline, Embase, Global Health, LILACS and the WHO Library databases were searched.
SELECTION CRITERIA: Publications from LMICs since 2015 describing maternal prophlyactic antibiotics for group B streptococcus (GBS), preterm-prelabor rupture of membranes (PPROM), cesarean section, manual placental removal, and third/fourth-degree perineal tears.
DATA COLLECTION AND ANALYSIS: Publications were screened, and duplicates were removed. A scoping review was conducted using PRISMA guidelines. Owing to study heterogeneity, a narrative synthesis was performed.
MAIN RESULTS: Of 1886 studies, 27 studies from 13 countries involving 43 774 women met the eligibility criteria. Polymerase chain reaction screening for GBS is feasible, though limited financially. In PPROM, up to 42% of GBS isolates demonstrated erythromycin resistance. Evidence around cesarean section antimicrobial prophylaxis largely supports WHO recommendations; however, prolonged or multidrug regimens were reported.
CONCLUSION: There is limited evidence to challenge current WHO recommendations to prevent peripartum infection in LMICs. However, implementation challenges exist. Given the emergence of antimicrobial resistance, research is needed to ensure that peripartum prophylactic antimicrobial choices remain effective.
参考来源
- Jury I, Thompson K, Hirst JE, et al. A scoping review of maternal antibiotic prophylaxis in low- and middle-income countries: Comparison to WHO recommendations for prevention and treatment of maternal peripartum infection. Int J Gynaecol Obstet. 2021. PMID: 33608872. doi:10.1002/ijgo.13648
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。